Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
SSTK
|
Jonathan Oringer
EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct | 30,074 Reduced 0.22% |
$1,947,292
$64.75 p/Share
|
Feb 01
2021 |
|
NOVA
|
Kris W Hillstrand
Officer |
SELL
Open market or private sale
|
Direct | 54,711 Reduced 83.21% |
$2,413,849
$44.12 p/Share
|
Feb 01
2021 |
|
TWST
|
Mark Daniels |
SELL
Open market or private sale
|
Direct | 1,166 Reduced 1.68% |
$194,419
$166.74 p/Share
|
Feb 01
2021 |
|
AMPH
|
Jack Y. Zhang
CEO & CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Indirect | 24,114 Reduced 0.34% |
$441,045
$18.29 p/Share
|
Feb 01
2021 |
|
SHAK
|
Daniel Harris Meyer
Director |
SELL
Open market or private sale
|
Indirect | 110,000 Reduced 2.51% |
$12,339,800
$112.18 p/Share
|
Feb 01
2021 |
|
DVAX
|
Robert Janssen
SVP and CMO |
SELL
Open market or private sale
|
Direct | 42,155 Reduced 32.77% |
$448,529
$10.64 p/Share
|
Feb 01
2021 |
|
RXT
|
Holly B. Windham
EVP, Chief Legal & People Off |
SELL
Open market or private sale
|
Direct | 106,917 Reduced 46.47% |
$2,429,154
$22.72 p/Share
|
Feb 01
2021 |
|
RXT
|
Subroto Mukerji
President - Americas Region |
SELL
Open market or private sale
|
Direct | 56,499 Reduced 60.51% |
$1,291,002
$22.85 p/Share
|
Feb 01
2021 |
|
LOB
|
Susan N Janson
Chief Risk Off., Live Oak Bank |
SELL
Open market or private sale
|
Direct | 3,500 Reduced 10.31% |
$140,315
$40.09 p/Share
|
Feb 01
2021 |
|
NMIH
|
Bradley M Shuster
Executive Chairman |
SELL
Open market or private sale
|
Direct | 36,628 Reduced 6.24% |
$794,095
$21.68 p/Share
|
Feb 01
2021 |
|
ZNTL
|
Anthony Y Sun
President & CEO |
SELL
Open market or private sale
|
Direct | 26,794 Reduced 1.51% |
$1,013,349
$37.82 p/Share
|
Feb 01
2021 |
|
ZNTL
|
Epperly Melissa B,
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 3,083 Reduced 1.12% |
$116,815
$37.89 p/Share
|
Feb 01
2021 |
|
ZNTL
|
Cam Gallagher
President, Interim CFO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 1.75% |
$377,100
$37.71 p/Share
|
Feb 01
2021 |
|
ZNTL
|
Kevin D. Bunker
Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect | 4,210 Reduced 2.82% |
$158,128
$37.56 p/Share
|
Feb 01
2021 |
|
ADPT
|
Julie Rubinstein
President and COO |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 100.0% |
$835,200
$55.68 p/Share
|
Feb 01
2021 |
|
ADPT
|
Harlan S Robins
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 7,790 Reduced 91.98% |
$435,149
$55.86 p/Share
|
Feb 01
2021 |
|
ADPT
|
Sharon Benzeno
Chief Commercial Ofc Imm Med |
SELL
Open market or private sale
|
Direct | 6,770 Reduced 100.0% |
$379,188
$56.01 p/Share
|
Feb 01
2021 |
|
QRTEA
|
Michael A George
Director |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 3.99% |
$1,246,000
$12.46 p/Share
|
Feb 01
2021 |
|
ARQT
|
Howard G. Welgus
Director |
SELL
Open market or private sale
|
Direct | 2,200 Reduced 1.19% |
$76,428
$34.74 p/Share
|
Feb 01
2021 |
|
ARQT
|
John W Smither
Chief Financial Officer |
SELL
Open market or private sale
|
Indirect | 3,750 Reduced 4.0% |
$131,250
$35.0 p/Share
|
Feb 01
2021 |
|
ARQT
|
John W Smither
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 1,250 Reduced 4.73% |
$43,750
$35.0 p/Share
|
Feb 01
2021 |
|
SNDX
|
Michael A Metzger
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 45.93% |
$302,850
$20.19 p/Share
|
Feb 01
2021 |
|
RVNC
|
Aubrey Rankin
Director |
SELL
Open market or private sale
|
Indirect | 33,119 Reduced 6.94% |
$859,438
$25.95 p/Share
|
Feb 01
2021 |
|
MORF
|
Praveen P. Tipirneni
President and CEO |
SELL
Open market or private sale
|
Indirect | 4,000 Reduced 0.32% |
$135,800
$33.95 p/Share
|
Feb 01
2021 |
|
MORF
|
Praveen P. Tipirneni
President and CEO |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 54.9% |
$135,840
$33.96 p/Share
|
Feb 01
2021 |
|
HCAT
|
Linda Llewelyn
Chief People Officer |
SELL
Open market or private sale
|
Direct | 1,717 Reduced 7.12% |
$84,391
$49.15 p/Share
|
Feb 01
2021 |
|
HCAT
|
Paul Horstmeier
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 10,750 Reduced 12.88% |
$533,523
$49.63 p/Share
|
Feb 01
2021 |
|
WRLD
|
John L Calmes Jr
Officer |
SELL
Open market or private sale
|
Direct | 1,600 Reduced 3.16% |
$224,064
$140.04 p/Share
|
Feb 01
2021 |
|
DCPH
|
Michael Douglas Taylor
Director |
SELL
Open market or private sale
|
Direct | 8,000 Reduced 100.0% |
$362,480
$45.31 p/Share
|
Feb 01
2021 |
|
GNK
|
Ccp Ii Cayman Gp Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 14,148 Reduced 0.67% |
$112,760
$7.97 p/Share
|
Feb 01
2021 |
|
GNK
|
Ccp Ii Cayman Gp Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 15,852 Reduced 0.73% |
$126,340
$7.97 p/Share
|
Feb 01
2021 |
|
GNK
|
Centerbridge Credit Partners, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 14,148 Reduced 0.67% |
$112,760
$7.97 p/Share
|
Feb 01
2021 |
|
GNK
|
Centerbridge Credit Partners, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 15,852 Reduced 0.73% |
$126,340
$7.97 p/Share
|
Feb 01
2021 |
|
YMAB
|
Thomas Gad
CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Indirect | 4,000 Reduced 0.66% |
$167,880
$41.97 p/Share
|
Feb 01
2021 |
|
YMAB
|
Thomas Gad
CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct | 7,000 Reduced 100.0% |
$293,930
$41.99 p/Share
|
Feb 01
2021 |
|
YEXT
|
Michael Walrath
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 177,579 Reduced 12.37% |
$3,029,498
$17.06 p/Share
|
Feb 01
2021 |
|
BLFS
|
Aby J. Mathew
EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 18,484 Reduced 9.29% |
$715,516
$38.71 p/Share
|
Feb 01
2021 |
|
CHRS
|
Jean Frederic Viret
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 7,402 Reduced 10.77% |
$159,513
$21.55 p/Share
|
Feb 01
2021 |
|
AMRN
|
Steven B Ketchum
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 217,728 Reduced 36.24% |
$1,752,710
$8.05 p/Share
|
Feb 01
2021 |
|
QNST
|
Douglas Valenti
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 2,084 Reduced 0.53% |
$44,848
$21.52 p/Share
|
Feb 01
2021 |
|
INGN
|
Brenton Taylor
EVP, Engineering |
SELL
Open market or private sale
|
Direct | 14,764 Reduced 20.69% |
$736,576
$49.89 p/Share
|
Feb 01
2021 |
|
RMNI
|
Kevin Maddock
EVP,ChiefRecurringRev.Officer |
SELL
Open market or private sale
|
Direct | 13,750 Reduced 33.16% |
$108,350
$7.88 p/Share
|
Feb 01
2021 |
|
RMNI
|
David W. Rowe
CPO,CMO&EVPGlob.Transformation |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 7.9% |
$120,000
$8.0 p/Share
|
Feb 01
2021 |
|
SRDX
|
Gary R Maharaj
President & CEO |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 2.07% |
$135,480
$45.16 p/Share
|
Feb 01
2021 |
|
RLMD
|
Paul Edward Kelly
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 31 Reduced 0.02% |
$1,085
$35.0 p/Share
|
Feb 01
2021 |
|
BAND
|
Kade Ross
Chief Information Officer |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 22.73% |
$178,130
$178.13 p/Share
|
Feb 01
2021 |
|
NKTX
|
James Trager
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 3,600 Reduced 7.1% |
$139,536
$38.76 p/Share
|
Feb 01
2021 |
|
ARCT
|
Pad Chivukula
Chief Scientific Officer & COO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 1.47% |
$753,100
$75.31 p/Share
|
Feb 01
2021 |
|
BTAI
|
Richard I Steinhart
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 3,750 Reduced 71.43% |
$180,563
$48.15 p/Share
|
Feb 01
2021 |
|
INO
|
Jong Joseph Kim
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 8.49% |
$1,500,000
$15.0 p/Share
|
Feb 01
2021 |